Retrospective analysis of mortalities associated with medication errors

American Journal of Health-System Pharmacy

Volumn 58, Issue 19, 2001, Pages 1835-1841

  Phillips, Jerry ^a,b   Beam, Sammie ^a   Brinker, Allen ^a   Holquist, Carol ^a   Honig, Peter ^a   Lee, Laureen Y ^a   Pamer, Carol ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Natl Coord Cncl Safe M   (United States)

Author keywords

Communication; Data collection; Death; Dosage; Drug administration routes; Errors; Food and Drug Administration (U.S.); Medication; Reports; Toxicity

Indexed keywords

ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG MISUSE; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; MORTALITY; PRIORITY JOURNAL;

EID: 0035478255     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.19.1835     Document Type: Article

References (19)

1. American Society of Health-System Pharmacists. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. Am J Health-Syst Pharm. 1998; 55:165-6.
2. Davies DM, ed. Textbook of adverse drug reactions. 3rd ed. New York: Oxford University Press; 1987.
3. Bates DW, Cullen DJ, Lavid N et al. Incidence of adverse drug events and potential adverse drug events. JAMA. 1995; 274:29.
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA. 1998; 279: 1200-5.
5. Porter J, Jick H. Drug-related deaths among medical inpatients. JAMA. 1977; 237:879-81.
6. Johnson JA, Bootman LJ. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995; 155:1949-56.
7. Classen DC, Pestotnik SL, Evans RS et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997; 266:301-6.
8. Leape LL, Brennan TA, Laird N et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991; 324: 377-84.
9. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997; 277:312-7.
10. National Coordinating Council for Medication Error Reporting and Prevention. Taxonomy of medication errors (1998) and Recommendations to correct error-prone aspects of prescription writing (1996). www.nccmerp.org (accessed 2001 Aug 24).
11. Abronheim JC. Special problems in the geriatric patient. In: Cecil RL, Bennett JC, eds. Cecil textbook of the geriatric patient. 21st ed. Vol. 1. St. Louis: Saunders; 1995: 22.
12. Honig PK, Cantilena LR. Polypharmacy. Pharmacokinetic perspectives. Clin Pharmacokinet. 1994; 26:85-90.
13. Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Med Care. 1991; 29:989-1003.
14. Col N, Fanale JE, Kronholm P. The role of medication non-compliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990; 150:841-5.
15. Fink A, Siu AL, Brook RH et al. Assuring the quality of health care for older persons. An expert panel's priorities. JAMA. 1987; 258:1905-8.
16. Prescription drugs and the elderly. Washington, DC: U.S. General Accounting Office, report no. HWHS-95-152; 1995 Jul:3.
17. Scott HD, Rosenbaum SE, Waters WJ et al. Rhode Island physicians' recognition and reporting of adverse drug reactions. R I Med J. 1987; 70:311-6.
18. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-70.
19. Katona BG, Ayd PR, Walters JK et al. Effect of a pharmacist's and a nurse's interventions on cost of drug therapy in a medical intensive-care unit. Am J Hosp Pharm. 1989; 46:1179-82.